Elevated levels of liver transaminases, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are considered biomarkers of hepatocellular damage, associated with fatty liver disease and hyperglycaemia in diabetes [33, 44, 51]. This evidence concerns the gene GPT and fatty liver disease.